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Abstract
 
Introduction
Medicaid  recipients  are  disproportionately  affected  by 
tobacco-related disease because their smoking prevalence 
is  approximately  53%  greater  than  that  of  the  overall 
US  adult  population.  This  study  estimates  state-level   
smoking-attributable Medicaid expenditures.
 
Methods
We  used  state-level  and  national  data  and  a  4-part 
econometric model to estimate the fraction of each state’s 
Medicaid  expenditures  attributable  to  smoking.  These 
fractions were multiplied by state-level Medicaid expen-
diture estimates obtained from the Centers for Medicare 
and Medicaid Services to estimate smoking-attributable 
expenditures.
 
Results
The  smoking-attributable  fraction  for  all  states  was 
11.0%  (95%  confidence  interval,  0.4%-17.0%).  Medicaid 
smoking-attributable expenditures ranged from $40 mil-
lion  (Wyoming)  to  $3.3  billion  (New  York)  in  2004  and 
totaled $22 billion nationwide.
 
Conclusion
Cigarette smoking accounts for a sizeable share of annual 
state Medicaid expenditures. To reduce smoking prevalence 
among recipients and the growth rate in smoking-attribut-
able Medicaid expenditures, state health departments and 
state health plans such as Medicaid are encouraged to pro-
vide free or low-cost access to smoking cessation counseling 
and medication.
Introduction
 
Medicaid is a means-tested entitlement program that 
provides  health  care  coverage  to  approximately  58  mil-
lion low-income Americans, many of whom would other-
wise be uninsured (1,2). The Medicaid program is jointly 
financed by the federal and state governments. In 2005, 
depending  on  a  state’s  average  personal  income  level, 
the federal Medicaid matching rate ranged from 50% to 
83% (1). The Congressional Budget Office estimates that 
federal Medicaid expenditures were $191 billion in 2007 
(3). Assuming an average Medicaid matching rate of 57%, 
program expenditures for all 50 states and the District 
of Columbia are projected to have exceeded $144 billion 
in 2007 (4,5). By 2018, total federal Medicaid spending is 
projected to be $445 billion, and assuming a 57% matching 
rate, total state Medicaid spending is projected to exceed 
$335 billion (3).
 
As a percentage of state budgets, Medicaid expenditures 
increased from 8% in 1985 to 21.5% in 2006, surpassing 
elementary and secondary education as the largest single 
budget item (2,5). Medicaid expenditures are expected to 
consume an ever-increasing share of state budgets, and 
many states will have difficulty meeting their Medicaid 
commitments  without  cutting  other  state-funded  pro-
grams  (1,5,6).  In  response  to  growing  concern  among 
state  governments,  the  chairman  and  vice-chairman  of 
the National Governors Association, in testimony before 
the US Senate Finance Committee, recommended placing 
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a greater emphasis on disease prevention as a means to 
contain rising Medicaid costs (6).
 
Tobacco-cessation programs are effective in lowering the 
prevalence of cigarette smoking and its consequent serious 
and costly medical conditions, including pregnancy-related 
complications, heart disease, respiratory illness, and sev-
eral  types  of  cancer  (7-9).  Tobacco-cessation  programs 
should target Medicaid recipients because smoking preva-
lence in the adult Medicaid population is approximately 
53% greater than that of the overall US adult population 
(34.5% vs 22.6% in 2006) (10).
 
We used data from the Medical Expenditure Panel Survey 
(MEPS)  and  the  Behavioral  Risk  Factor  Surveillance 
System (BRFSS) to update previous estimates of Medicaid 
smoking-attributable  medical  expenditures  at  the  state 
level  (11).  These  estimates  might  assist  state  health 
departments and Medicaid in formulating effective smok-
ing-cessation polices to help reduce the high prevalence of 
cigarette use among their recipients.
Methods
Data
 
We used the 2001 and 2002 MEPS to develop a model 
that predicts smoking-attributable medical expenditures 
for the Medicaid population. MEPS is a nationally rep-
resentative  survey  of  the  civilian,  noninstitutionalized 
population that quantifies each participant’s total annual 
medical spending, including expenditures from public- and 
private-sector health insurers and out-of-pocket payments. 
The data also include information about each participant’s 
source of health insurance (eg, any evidence of Medicaid 
coverage  during  the  year)  and  sociodemographic  char-
acteristics  (such  as  race/ethnicity,  sex,  and  education). 
Information about MEPS is available at www.meps.ahrq.
gov/mepsweb/.
 
The MEPS sampling frame is drawn from participants 
in the National Health Interview Survey (NHIS). NHIS 
is a nationally representative survey that collects data on 
selected health topics. Although MEPS does not capture 
information on smoking, self-reported smoking variables 
are available for a subset of adult NHIS participants (the 
Adult Sample File) and can be merged with MEPS data. 
We used responses to the question “Have you smoked at 
least 100 cigarettes in your entire life?” to differentiate 
between ever smokers and nonsmokers. We excluded from 
the  analysis  sample  respondents  with  missing  data  on 
smoking variables (≈1% of respondents aged ≥18 years and 
all respondents aged <18 at the time of the NHIS inter-
view) and those who did not receive Medicaid coverage. 
Our final MEPS-NHIS population included 1,588 adults 
with  weighting  variables  that  allowed  us  to  generate 
nationally representative estimates of the adult, civilian, 
noninstitutionalized Medicaid population (Table 1).
 
Before  constructing  our  national  model,  we  used  the 
Medical Care component of the Consumer Price Index to 
inflate all MEPS annual medical spending data to 2004 
dollars.
State-level representative data
 
The  BRFSS  is  a  state-based  telephone  survey  of  the 
adult  (aged  ≥18),  noninstitutionalized  population  that 
tracks health risks in the United States. The most recent 
BRFSS surveys do not allow for stratifying participants 
by type of health insurance. This information was, how-
ever, available before 2001. Therefore, we used 1998-2000 
BRFSS data to predict state-level medical expenditures 
for the Medicaid population. Information about BRFSS is 
available at www.cdc.gov/BRFSS/. Although BRFSS does 
not collect medical expenditure data, it includes informa-
tion about each participant’s smoking status, insurance 
status (before 2001), and sociodemographic characteristics 
(such as race/ethnicity, sex, and education). Because these 
variables match those from MEPS-NHIS, we were able to 
construct  an  expenditure  prediction  model  with  MEPS-
NHIS data and use the results to generate expenditure 
estimates  for  smokers  and  nonsmokers  on  the  basis  of 
state-representative population characteristics of BRFSS 
participants.
 
As we did with our MEPS-NHIS restrictions, we exclud-
ed those with missing smoking data (≈1%) and those who 
did not receive Medicaid coverage. Our final BRFSS popu-
lation  included  16,201  adults  with  weighting  variables 
that allowed us to generate state-representative estimates 
of  the  adult,  noninstitutionalized  Medicaid  population 
(Table 1).
 
Estimating state-specific smoking-attributable medical 
expenditures for the Medicaid population involved 3 steps. 
First, we used MEPS-NHIS data to create a model that 
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ents as a function of smoking status, body weight, and 
sociodemographic characteristics. Second, we used state-
representative BRFSS data and results from our MEPS-
NHIS national model to estimate the fraction of medical 
expenditures for Medicaid recipients that was attributable 
to smoking for each state. Third, we multiplied these frac-
tions by previously published estimates of state-specific 
Medicaid  expenditures  to  compute  smoking-attributable 
Medicaid  expenditures  for  each  state.  These  steps  are 
described in detail below.
MEPS-NHIS national model
 
We  used  a  4-part  regression  model  to  predict  annual 
medical  expenditures  for  each  MEPS-NHIS  Medicaid 
recipient. The 4-part regression approach was pioneered 
by authors of the RAND Health Insurance Experiment to 
control for several unique characteristics of the medical 
expenditures distribution and is now commonly applied to 
medical expenditures data (12,13). The model estimates 
predicted expenditures by using the following functional 
form: EXP = Pr(C × EXPIP + [1 − C]EXPNIP), where EXP 
represents predicted annual expenditures; Pr represents 
the predicted probability of positive medical expenditures 
during the year and is estimated with a logistic regression 
model;  C  represents  the  conditional  probability  of  posi-
tive inpatient expenditures, given positive expenditures, 
and is estimated with a logistic regression model; EXPIP 
represents ordinary least squares (OLS)-predicted medi-
cal  expenditures,  given  positive  inpatient  expenditures 
during  the  year;  and  EXPNIP  represents  OLS-predicted 
medical expenditures, given positive expenditures but no 
inpatient expenditures.
 
All OLS regression models are estimated on the logged 
expenditure variable to adjust for the skewness in annual 
expenditures (mean annual expenditures are significantly 
greater than the median). Logged expenditures are con-
verted back to expenditures by using the homoscedastic 
smearing factor (14).
 
Including dummy variables that indicate smoking sta-
tus (ever smoked set equal to 1 and the referent group, 
never smoked, set equal to 0) in each regression model 
allowed us to quantify the effect of smoking on annual 
medical expenditures. In addition to smoking status, all 
regressions controlled for other variables assumed to influ-
ence annual medical expenditures, including self-reported 
body weight, sex, race/ethnicity, age, region of residence, 
education,  and  marital  status.  Regression  models  were 
estimated by using SUDAAN version 8 (RTI International, 
Research Triangle Park, North Carolina) to control for the 
complex survey design used in MEPS-NHIS. Table 2 pres-
ents results from the 4-part regression model.
BRFSS state-level estimates
 
We used the coefficient estimates from the MEPS-NHIS 
models to predict annual medical expenditures for each 
BRFSS Medicaid recipient. To do this, we multiplied each 
person’s  characteristics  (the  independent  variables)  by 
his  respective  coefficients  generated  from  the  4  MEPS-
NHIS regression models and combined the results with 
the equation above. Using the BRFSS weighting variables 
and each person’s predicted medical expenditures, we com-
puted total predicted medical expenditures for each state’s 
Medicaid population.
 
We  estimated  smoking-attributable  medical  expendi-
tures as the difference between predicted expenditures for 
ever  smokers  and  predicted  expenditures  for  nonsmok-
ers, leaving all other variables unchanged. This method 
allowed us to isolate the effect of smoking while main-
taining  any  other  population  characteristics  that  may 
contribute to higher annual medical expenditures among 
smokers.
 
For the Medicaid population in each state, the percentage 
of aggregate medical expenditures attributable to smoking 
was calculated by dividing aggregate predicted expenditures 
attributable to smoking by total predicted expenditures for 
adult Medicaid recipients in each state. Because BRFSS is 
limited to adults, our results should be interpreted as the 
fraction of adult medical expenditures that are attributable 
to smoking among adults in each state.
Estimating total and public-sector expenditures
 
For a variety of reasons, including the lack of data on 
institutionalized  populations,  MEPS  national  spending 
estimates  (and  state-level  spending  estimates  based  on 
MEPS) underestimate actual US health care spending (15). 
Therefore, to quantify annual adult smoking-attributable 
medical  expenditures  for  each  state,  we  multiplied  our 
state-by-state smoking-attributable fractions by published 
estimates  of  2001  state-specific  Medicaid  expenditures, 
available  from  the  Centers  for  Medicare  and  Medicaid 
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Services (16). We used 2001 because it is the most recent 
year  that  annual,  state-specific  Medicaid  expenditure 
estimates are available. To match our regression popula-
tion, we limited Medicaid expenditures to those accrued 
by adult recipients (≥18 years). We then inflated medical 
expenditure estimates to 2004 by using a national adjust-
ment factor (1.31). This adjustment factor, calculated as 
the ratio of 2004 projected expenditures (actual expendi-
tures not yet available) to 2001 actual expenditures, was 
based on data from Centers for Medicare and Medicaid 
Services National Health Expenditure Accounts, gener-
ally considered the standard for measuring annual health 
care spending (17).
Results
 
State-specific  estimates  of  smoking  prevalence  among 
Medicaid recipients vary considerably across states and 
range from 35% (Mississippi) to 80% (New Hampshire) 
(Table 3). Nationally, approximately 11% (95% confidence 
interval,  0.4%-17.0%)  of  adult  Medicaid  expenditures 
are attributable to smoking. At the state level, smoking-
attributable fractions range from 6% (New Jersey) to 18% 
(Arizona and Washington).
 
Smoking-attributable medical expenditures in the adult 
Medicaid population total $22 billion. State-level smoking-
attributable medical expenditures among adult Medicaid 
recipients range from $40 million (Wyoming) to $3.3 bil-
lion (New York) (Figure).
 
Discussion
 
The 2000 Public Health Service (PHS) clinical practice 
guideline  for  treating  tobacco  dependence  recommends 
individual,  group,  and  telephone  counseling,  as  well  as 
5 medications (18). Treating tobacco dependence is more 
cost-effective than commonly covered preventive services 
such as mammography or treatment of mild to moderate 
hypertension (19). In 2002, however, only 10 states report-
ed  using  the  2000  PHS  guideline  to  design  treatment 
benefits and programs for Medicaid recipients or to train 
Medicaid health care providers. Moreover, only 5 states 
required providers or health plans to document tobacco 
use in patients’ medical charts, and only 2 states offered 
all  counseling  and  pharmacotherapy  treatments  recom-
mended by the guideline to their Medicaid recipients (20).
 The  growth  rate  in  Medicaid  expenditures  has  led 
the  National  Governors  Association  to  propose  a  bipar-
tisan plan to reform the program. A key element of this 
plan is to make Medicaid more effective and efficient by 
developing policies that will “maintain or even [improve] 
health outcomes while potentially saving money for both 
the states and the federal government” (6). One way to 
improve the health of Medicaid recipients and potentially 
reduce  the  rate  of  growth  in  Medicaid  program  expen-
ditures  is  by  covering  PHS-recommended  treatments, 
including individual and group telephone counseling and 
approved drugs (9,21-24).
Strengths and limitations
 
The  MEPS-NHIS  national  model  that  was  used  to 
calculate  our  state-level  estimates  is  an  improvement 
on  a  previous  study  that  used  data  from  the  1987 
National Medical Expenditure Survey (NMES) to estimate   
smoking-attributable Medicaid expenditures (11). Results 
from the 1987 NMES are dated, and unlike NHIS, many of 
the key smoking variables that NMES used were imputed 
(25). Using recent data and actual, as opposed to imputed, 
smoking information in our calculations provides states 
with updated and accurate information that may better 
inform policy decisions. In addition, these differences may, 
in part, explain why the nationwide Medicaid smoking-
attributable fraction of 11.0% is more conservative than 
the previous estimate of 14.5% generated for 1993 (11). 
Other changes that may account for the difference in our 
estimated smoking-attributable fraction include potential 
changes  in  the  number  of  people  treated  for  smoking- 
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Figure. State-by-state distribution of Medicaid smoking-attributable medical 
expenditures.related illness from 1993 to 2002 and any change in treat-
ment disposition from inpatient to outpatient care. Finally, 
our estimates differ from previous estimates, and probably 
understate  Medicaid  smoking-attributable  expenditures, 
because they exclude expenditures for nursing home care, 
which are not available in the MEPS-NHIS model.
 
Despite these strengths, our study has several limita-
tions. First, both the MEPS-NHIS and BRFSS are lim-
ited to noninstitutionalized populations, but we apply the 
resulting  smoking-attributable  fractions  to  expenditure 
estimates that include both institutionalized and nonin-
stitutionalized  populations.  If  these  fractions  are  differ-
ent for the institutionalized population, our expenditure 
estimates would be biased. Second, data limitations pre-
cluded  us  from  quantifying  smoking-attributable  medi-
cal expenditures for smokers younger than 18 years and 
nonsmokers exposed to secondhand smoke. The effects of 
secondhand smoke on children’s health are considerable 
(7). Secondhand smoke exposure can lead to acute lower 
respiratory infections, such as bronchitis and pneumonia 
in infants and young children, and can cause children who 
already  have  asthma  to  experience  more  frequent  and 
severe  attacks  (26).  Although  health  care  expenditures 
attributable to secondhand smoke exposure may be high, 
quantifying  these  expenditures  is  difficult.  As  a  conse-
quence,  our  estimates  understate  smoking-attributable 
expenditures. Third, our analysis is limited to health care 
expenditures and therefore does not address other expens-
es  (eg,  disability,  decreased  productivity,  absenteeism) 
that result from smoking (7). Finally, because our focus 
was not to test statistically whether smoking-attributable 
expenditures were larger in some states than others, we 
did not calculate standard errors at the state level.
Conclusions
 
An estimated 443,000 Americans die prematurely each 
year as a result of smoking or exposure to secondhand 
smoke  (27).  Medicaid  recipients  are  disproportionately 
affected by tobacco-related disease because their smoking 
prevalence is approximately 53% greater than that of the 
overall US adult population (10). In addition to the indi-
vidual health toll, the disproportionately higher smoking 
prevalence among Medicaid recipients imposes substan-
tial costs on society. We estimate that smoking accounts 
for approximately 11% of Medicaid program expenditures. 
To improve the health of Medicaid recipients and poten-
tially reduce the growth rate of expenditures, Medicaid 
programs in all 50 states and the District of Columbia are 
encouraged to follow the 2000 PHS guidelines and cover 
all  recommended  tobacco-dependence  treatments  and 
approved medications (18). The cost-effectiveness of these 
programs, combined with the high cost of smoking, sug-
gests that such coverage may provide cost savings to the 
financially strapped Medicaid programs.
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Table 1. Characteristics of Adult MEPS-NHIS (2001 and 2002) and BRFSS (1998-2000) Medicaid Recipients With Data on 
Smoking Statusa
Characteristic
MEPS-NHIS BRFSS
Nonsmokers (n = 768) Ever Smokers (n = 820) Nonsmokers (n = 7,701) Ever Smokers (n = 8,500)
Sex
Male 21 33 23 32
Female 79 67 77 68
Race/ethnicity
White 32 60 32 58
Black 3 23 28 21
Hispanic 26 12 35 17
Asian 6 2 3 1
Other 1 3 1 3
Mean age, y 36 0 36 38
Region of residence
Northeast 20 19 36 29
Midwest 21 2 11 18
South 35 38 28 28
West 2 18 25 25
Weight category
Underweight 2 3 3 3
Normal 2 31 33 37
Overweight 36 31 29 30
Obese 36 3 30 26
Missing data 2 1 6 3
Education
Less than high school graduate 35 3 33 38
High school graduate 56 58 61 58
College graduate 9 8 6 
Marital status
Married 3 2 37 32
Widowed  3 5 
Divorced/separated 2 35 18 27
Single 39 38 0 37
 
Abbreviations: MEPS, Medical Expenditure Panel Survey; NHIS, National Health Interview Survey; BRFSS, Behavioral Risk Factor Surveillance System. 
a All data are percentages, except age.
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Table 2. Four-Part Model Regression of the Effect of Smoking on Annual Medical Expenditures
Variable
Correlation (Standard Error)
Probability of Positive 
Expenditures
Probability of Positive 
Inpatient Expenditures
Logged Expenditures for 
Users of Inpatient Services
Logged Expenditures for 
Nonusers of Inpatient 
Services
Intercept .19 (1.62) −1.51 (1.21) 9.39 (0.80) 5.1 (0.70)
Smoking status
Nonsmoker Reference Reference Reference Reference
Ever smoker 0.06 (0.2) 0.22 (0.1) 0.13 (0.11) 0.05 (0.12)
Weight category
Underweight 0.06 (0.89) 0.35 (0.56) 0.6 (0.51) 0.5 (0.38)
Normal weight Reference Reference Reference Reference
Overweight −0.08 (0.27) −0.24 (0.27) −0.16 (0.20) −0.04 (0.16)
Obese 0.28 (0.26) 0.3 (0.26) −0.02 (0.20) 0.21 (0.13)
Missing data −0.88 (0.48) −1.71 (0.72) 0.62 (0.22) 0.79 (0.3)
Sex
Male Reference Reference Reference Reference
Female 0.81 (0.2) −0.29 (0.24) 0.01 (0.16) 0.33 (0.18)
Race/ethnicity
White Reference Reference Reference Reference
Black −0.79 (0.30) −0.34 (0.22) −0.26 (0.16) −0.57 (0.18)
Hispanic −0.85 (0.28) −0.08 (0.26) −0.19 (0.13) −0.55 (0.17)
Asian −1.17 (0.54) −0.72 (0.63) −0.76 (0.35) −0.85 (0.39)
Other −0.96 (0.70) −0.26 (0.59) 0.59 (0.36) 0.62 (0.30)
Age −0.22 (0.10) −0.04 (0.06) −0.01 (0.04) 0.01 (0.0)
Age squared 0.00 (0.00) 0.00 (0.00) −0.00 (0.00) 0.00 (0.00)
Region of residence
Northeast Reference Reference Reference Reference
Midwest −0.22 (0.40) 0.17 (0.28) 0.23 (0.17) 0.1 (0.25)
South −0.33 (0.33) 0.37 (0.2) 0.10 (0.15) 0.19 (0.20)
West 0.12 (0.31) −0.17 (0.28) 0.20 (0.20) 0.09 (0.21)
Education
Less than high school 
diploma
Reference Reference Reference Reference
High school diploma 0.37 (0.22) 0.18 (0.19) −0.03 (0.12) 0.15 (0.12)
College 0.87 (0.65) 0.06 (0.31) −0.21 (0.24) 0.03 (0.25)
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(Continued on next page)Variable
Correlation (Standard Error)
Probability of Positive 
Expenditures
Probability of Positive 
Inpatient Expenditures
Logged Expenditures for 
Users of Inpatient Services
Logged Expenditures for 
Nonusers of Inpatient 
Services
Marital status
Married Reference Reference Reference Reference
Widowed 0. (0.77) 0.28 (0.8) 0.2 (0.28) 0.71 (0.33)
Divorced/separated 1.30 (0.30) −0.05 (0.21) 0.07 (0.16) 0.2 (0.13)
Single 0.35 (0.22) −0.09 (0.21) 0.01 (0.1) 0.19 (0.1)
Pregnancy
Not pregnant Reference Reference Reference Reference
Pregnant 3.67 (1.09) 3.77 (1.17) −1.69 (0.59) −0.64 (0.54)
R2 0.10 0.13 0.21 0.17
Table 3. Smoking Prevalence and Estimated Fraction and Total Annual Medicaid Expenditure Attributable to Smoking, by 
State
State Smoking Prevalence, % SAF, %a SAE, million, 2004 $
Alabama 52 9 285
Alaska 68 15 67
Arizona 9 18 377
Arkansas 5 11 167
California 5 11 2,25
Colorado 61 17 338
Connecticut 9 7 29
Delaware 58 10 55
District of Columbia 51 11 95
Florida 6 11 951
Georgia 2 10 372
Hawaii 62 11 69
Idaho 62 1 97
Illinois 58 11 905
Indiana 68 15 521
Iowa 61 10 166
Kansas 5 12 171
 
Abbreviations: SAF, smoking-attributable fraction; SAE, smoking-attributable expenditure. 
a Estimates for states are based on Behavioral Risk Factor Surveillance System state-representative data and the Medical Expenditure Panel Survey and 
National Health Interview Survey (MEPS-NHIS) national model. The fraction for the United States as a whole is based solely on the MEPS-NHIS national model.
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Table 2. (continued) Four-Part Model Regression of the Effect of Smoking on Annual Medical Expenditures
(Continued on next page)VOLUME 6: NO. 3
JULY 2009
State Smoking Prevalence, % SAF, %a SAE, million, 2004 $
Kentucky 65 12 390
Louisiana 3 12 36
Maine 63 1 190
Maryland 51 12 386
Massachusetts 53 11 696
Michigan 6 13 727
Minnesota 5 11 23
Mississippi 35 9 197
Missouri 66 1 51
Montana 70 15 70
Nebraska 6 15 167
Nevada 62 11 66
New Hampshire 80 15 103
New Jersey 36 6 309
New Mexico 50 12 159
New York 5 11 3,33
North Carolina 63 11 622
North Dakota 63 12 53
Ohio 65 13 1,171
Oklahoma 58 12 233
Oregon 67 15 290
Pennsylvania 70 11 89
Rhode Island 8 8 9
South Carolina 1 11 336
South Dakota 69 16 68
Tennessee 58 11 3
Texas 3 11 987
Utah 5 1 19
Vermont 67 15 7
Virginia 58 11 29
Washington 67 18 6
West Virginia 67 11 180
Wisconsin 63 13 0
Wyoming 62 16 0
US total 51 11 21,951
 
Abbreviations: SAF, smoking-attributable fraction; SAE, smoking-attributable expenditure. 
a Estimates for states are based on Behavioral Risk Factor Surveillance System state-representative data and the Medical Expenditure Panel Survey and 
National Health Interview Survey (MEPS-NHIS) national model. The fraction for the United States as a whole is based solely on the MEPS-NHIS national model.
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Table 3. (continued) Smoking Prevalence and Estimated Fraction and Total Annual Medicaid Expenditure Attributable to 
Smoking, by State